These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33743480)

  • 1. SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC).
    Gauci ML; Coutzac C; Houot R; Marabelle A; Lebbé C;
    Eur J Cancer; 2021 May; 148():121-123. PubMed ID: 33743480
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors.
    Waissengrin B; Agbarya A; Safadi E; Padova H; Wolf I
    Lancet Oncol; 2021 May; 22(5):581-583. PubMed ID: 33812495
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 vaccines: modes of immune activation and future challenges.
    Teijaro JR; Farber DL
    Nat Rev Immunol; 2021 Apr; 21(4):195-197. PubMed ID: 33674759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 vaccines for cancer patients: a call to action.
    Corti C; Crimini E; Tarantino P; Pravettoni G; Eggermont AMM; Delaloge S; Curigliano G
    Eur J Cancer; 2021 May; 148():316-327. PubMed ID: 33770576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
    Kuhlmann C; Mayer CK; Claassen M; Maponga T; Burgers WA; Keeton R; Riou C; Sutherland AD; Suliman T; Shaw ML; Preiser W
    Lancet; 2022 Feb; 399(10325):625-626. PubMed ID: 35063123
    [No Abstract]   [Full Text] [Related]  

  • 6. Fast Development of High-Quality Vaccines in a Pandemic.
    Pischel L; Yildirim I; Omer SB
    Chest; 2021 Jul; 160(1):e1-e3. PubMed ID: 33848535
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
    Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P
    Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborns' passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy.
    Gloeckner S; Hornung F; Heimann Y; Schleussner E; Deinhardt-Emmer S; Loeffler B; Zoellkau J
    Am J Obstet Gynecol; 2022 Feb; 226(2):261-262. PubMed ID: 34648744
    [No Abstract]   [Full Text] [Related]  

  • 9. Can families believe the accuracy of websites' information regarding COVID-19 vaccines' side effects?
    Harvey-Nguyen L; Tuthill D
    Arch Dis Child; 2022 Mar; 107(3):e24. PubMed ID: 34906965
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombocytopenia after COVID-19 vaccination.
    Kragholm K; Sessa M; Mulvad T; Andersen MP; Collatz-Christensen H; Blomberg SN; Lippert F; Mikkelsen S; Leutscher P; Melgaard D; Torp-Pedersen C; Kristensen SR; Larsen TB; Sogaard P
    J Autoimmun; 2021 Sep; 123():102712. PubMed ID: 34332437
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccines surveillance in France: a global response to a major national challenge.
    Benkebil M; Gautier S; Gras-Champel V; Massy N; Micallef J; Valnet Rabier MB
    Anaesth Crit Care Pain Med; 2021 Jun; 40(3):100866. PubMed ID: 33895471
    [No Abstract]   [Full Text] [Related]  

  • 12. What gastroenterologists should know about SARS-CoV 2 vaccine: World Endoscopy Organization perspective.
    Spadaccini M; Canziani L; Aghemo A; Lleo A; Maselli R; Anderloni A; Carrara S; Fugazza A; Pellegatta G; Galtieri PA; Hassan C; Greenwald D; Pochapin M; Wallace M; Sharma P; Roesch T; Bhandari P; Emura F; Raju GS; Repici A
    United European Gastroenterol J; 2021 Sep; 9(7):787-796. PubMed ID: 34102015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immune activation of the COVID vaccines: ChAdOx1, BNT162b2, mRNA-1273, BBIBP-CorV, and Gam-COVID-Vac from serological human samples in Hungary showed higher protection after mRNA-based immunization.
    Fodor E; Olmos Calvo I; Kuten-Pella O; Hamar E; Bukva M; Madár Á; Hornyák I; Hinsenkamp A; Hetényi R; Földes F; Brigitta Z; Jakab F; Kemenesi G; Lacza Z
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5297-5306. PubMed ID: 35916830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations.
    Abid MB
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19.
    Cha HH; Lim SY; Kwon JS; Kim JY; Bae S; Jung J; Kim SH
    Korean J Intern Med; 2022 Mar; 37(2):455-459. PubMed ID: 35272444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
    Madhavan M; Ritchie AJ; Aboagye J; Jenkin D; Provstgaad-Morys S; Tarbet I; Woods D; Davies S; Baker M; Platt A; Flaxman A; Smith H; Belij-Rammerstorfer S; Wilkins D; Kelly EJ; Villafana T; Green JA; Poulton I; Lambe T; Hill AVS; Ewer KJ; Douglas AD
    EBioMedicine; 2022 Nov; 85():104298. PubMed ID: 36229342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety.
    Luxi N; Giovanazzi A; Capuano A; Crisafulli S; Cutroneo PM; Fantini MP; Ferrajolo C; Moretti U; Poluzzi E; Raschi E; Ravaldi C; Reno C; Tuccori M; Vannacci A; Zanoni G; Trifirò G;
    Drug Saf; 2021 Dec; 44(12):1247-1269. PubMed ID: 34739716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2.
    Markewitz R; Juhl D; Pauli D; Görg S; Junker R; Rupp J; Engel S; Steinhagen K; Herbst V; Zapf D; Krüger C; Brockmann C; Leypoldt F; Dargvainiene J; Schomburg B; Sharifzadeh S; Nejad LS; Wandinger KP; Ziemann M
    Front Immunol; 2022; 13():811020. PubMed ID: 35126395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does COVID-19 Vaccination Warrant the Classical Principle "
    Doulberis M; Papaefthymiou A; Kotronis G; Gialamprinou D; Soteriades ES; Kyriakopoulos A; Chatzimichael E; Kafafyllidou K; Liatsos C; Chatzistefanou I; Anagnostis P; Semenin V; Ntona S; Gkolia I; Papazoglou DD; Tsinonis N; Papamichos S; Kirbas H; Zikos P; Niafas D; Kountouras J
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactogenicity among health care workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine.
    Baldolli A; Fournier A; Verdon R; Michon J
    Clin Microbiol Infect; 2022 Jun; 28(6):885.e1-885.e5. PubMed ID: 35182759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.